X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7675) 7675
Publication (380) 380
Newsletter (113) 113
Book Review (44) 44
Book Chapter (19) 19
Magazine Article (19) 19
Conference Proceeding (10) 10
Book / eBook (6) 6
Newspaper Article (4) 4
Dissertation (3) 3
Trade Publication Article (3) 3
Transcript (2) 2
Government Document (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
nitroglycerin - pharmacology (4981) 4981
humans (3938) 3938
male (3899) 3899
animals (3478) 3478
female (2514) 2514
nitroglycerin (2428) 2428
vasodilator agents - pharmacology (1786) 1786
middle aged (1778) 1778
pharmacology & pharmacy (1633) 1633
adult (1607) 1607
blood pressure - drug effects (1394) 1394
rats (1192) 1192
nitroglycerin - administration & dosage (1188) 1188
dogs (1131) 1131
aged (1037) 1037
cardiac & cardiovascular systems (1009) 1009
vasodilation - drug effects (985) 985
in vitro techniques (976) 976
hemodynamics - drug effects (950) 950
nitroglycerin - therapeutic use (894) 894
heart rate - drug effects (848) 848
nitric oxide (843) 843
nitric-oxide (780) 780
index medicus (743) 743
dose-response relationship, drug (733) 733
coronary vessels - drug effects (598) 598
glyceryl trinitrate (593) 593
coronary circulation - drug effects (579) 579
acetylcholine - pharmacology (560) 560
time factors (556) 556
muscle, smooth, vascular - drug effects (540) 540
rabbits (506) 506
peripheral vascular disease (498) 498
angina pectoris - drug therapy (483) 483
endothelium, vascular - drug effects (472) 472
nitroprusside - pharmacology (472) 472
drug tolerance (462) 462
nitrates (462) 462
endothelium (449) 449
nitric oxide - metabolism (445) 445
vascular resistance - drug effects (445) 445
organic nitrates (398) 398
rats, sprague-dawley (379) 379
vasodilation (376) 376
coronary disease - physiopathology (375) 375
blood pressure (363) 363
heart - drug effects (348) 348
physiology (342) 342
vasodilator agents - administration & dosage (341) 341
relaxation (327) 327
vasodilator agents - therapeutic use (325) 325
nitrate tolerance (321) 321
double-blind method (320) 320
electrocardiography (317) 317
muscle relaxation - drug effects (312) 312
endothelium, vascular - physiology (310) 310
endothelium, vascular - physiopathology (304) 304
muscle contraction - drug effects (299) 299
norepinephrine - pharmacology (299) 299
regional blood flow - drug effects (298) 298
vasodilation - physiology (293) 293
acetylcholine (290) 290
nitrates - pharmacology (282) 282
isosorbide dinitrate - pharmacology (278) 278
myocardium - metabolism (278) 278
vasoconstriction - drug effects (275) 275
surgery (274) 274
rats, wistar (272) 272
vascular smooth-muscle (270) 270
nitroglycerin - metabolism (268) 268
cardiovascular system (266) 266
coronary disease - drug therapy (263) 263
nitric oxide donors - pharmacology (259) 259
nitric oxide - physiology (252) 252
phenylephrine - pharmacology (252) 252
hypertension (251) 251
cardiac output - drug effects (250) 250
research (247) 247
relaxing factor (245) 245
tolerance (239) 239
smooth-muscle (238) 238
atherosclerosis (235) 235
biochemistry & molecular biology (226) 226
myocardial contraction - drug effects (226) 226
swine (226) 226
hemodynamics (223) 223
injections, intravenous (222) 222
isosorbide dinitrate (222) 222
administration, cutaneous (221) 221
arginine - pharmacology (219) 219
infusions, intravenous (218) 218
cyclic gmp - metabolism (217) 217
administration, oral (216) 216
mechanism (214) 214
exercise test (212) 212
propranolol - pharmacology (212) 212
heart failure - drug therapy (210) 210
angina pectoris - physiopathology (209) 209
drug interactions (207) 207
inhibition (205) 205
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7041) 7041
German (204) 204
Russian (170) 170
Japanese (120) 120
French (104) 104
Italian (67) 67
Chinese (32) 32
Polish (23) 23
Spanish (21) 21
Czech (15) 15
Ukrainian (9) 9
Korean (6) 6
Portuguese (5) 5
Danish (4) 4
Romanian (4) 4
Dutch (3) 3
Bulgarian (2) 2
Lithuanian (2) 2
Turkish (2) 2
Hungarian (1) 1
Norwegian (1) 1
Slovak (1) 1
Slovenian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Cardiovascular Pharmacology, ISSN 0160-2446, 09/2004, Volume 44, Issue 3, pp. 302 - 309
The mechanisms involved in the cardioprotector effect of red wine have not yet been completely elucidated but probably an endothelium-dependent vasodilator... 
Antihypertensive | EDHF | Brazilian red wine | Vasodilation | Endothelium | Flavonoids - antagonists & inhibitors | Male | Nitroglycerin - pharmacology | Yohimbine - pharmacology | Glyburide - pharmacology | Charybdotoxin - pharmacology | Oxadiazoles - pharmacology | Phenols - antagonists & inhibitors | Brazil | Polyphenols | Wine - adverse effects | Muscle, Smooth, Vascular - drug effects | Phenols - pharmacology | Administration, Oral | Rats | Atropine - pharmacology | Pressure | Vasoconstriction - drug effects | Indomethacin - pharmacology | Phenols - analysis | Pyrilamine - pharmacology | Perfusion | Vasodilation - drug effects | Quinazolines - pharmacology | Bradykinin - analogs & derivatives | Norepinephrine - pharmacology | Flavonoids - analysis | Rats, Wistar | Nitric Oxide Synthase - antagonists & inhibitors | Mesenteric Arteries - drug effects | Guanylate Cyclase - antagonists & inhibitors | Apamin - pharmacology | Endothelium, Vascular - physiology | Quinoxalines - pharmacology | Hypertension - chemically induced | Potassium Chloride - pharmacology | Hypertension - prevention & control | Clonidine - pharmacology | Blood Pressure - drug effects | Flavonoids - pharmacology | Vasodilation - physiology | Drug Therapy, Combination | Oxadiazoles - chemistry | Quinazolines - chemistry | Bradykinin - pharmacology | Acetylcholine - pharmacology | NG-Nitroarginine Methyl Ester - adverse effects | Alcohol Drinking - adverse effects | Clonidine - antagonists & inhibitors | Animals | Deoxycholic Acid - pharmacology | Acetylcholine - antagonists & inhibitors
Journal Article
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 04/1996, Volume 97, Issue 8, pp. 1916 - 1923
We tested the hypothesis that angiotensin II-induced hypertension is associated with an increase in vascular . O-2(-) production, and characterized the oxidase... 
Hypertension | Superoxide | Angiotensin II | Nitric oxide | Endothelium | MEDICINE, RESEARCH & EXPERIMENTAL | endothelium | nitric oxide | MYOCARDIAL-INFARCTION | RENIN | angiotensin II | NITRIC-OXIDE | DYSFUNCTION | INDUCTION | superoxide | hypertension | SMOOTH-MUSCLE CELLS
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2013, Volume 32, Issue 6, pp. 633 - 640
Background The cardioprotective efficacy of erythropoietin (EPO) has been widely documented in rodent models of acute coronary syndrome. We sought to evaluate... 
Surgery | heart transplantation | heart preservation | Celsior solution | glyceryl trinitrate | zoniporide | ischemia–reperfusion injury | erythropoietin | ischemia-reperfusion injury | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | REPERFUSION INJURY | AKT | MODEL | PROTECTS | CARIPORIDE | TRANSPLANTATION | IN-VITRO | INHIBITION | RESPIRATORY SYSTEM | CARDIOPROTECTION | ISCHEMIA/REPERFUSION | SIGNAL TRANSDUCER | Erythropoietin - pharmacology | Electrolytes - therapeutic use | Glutamates - therapeutic use | Histidine - pharmacology | Pyrazoles - therapeutic use | Rats, Wistar | Recovery of Function - drug effects | Erythropoietin - therapeutic use | Guanidines - pharmacology | Male | Cold Ischemia | Histidine - therapeutic use | Nitroglycerin - pharmacology | Mannitol - pharmacology | Dose-Response Relationship, Drug | Disaccharides - pharmacology | Heart Rate - drug effects | Glutathione - pharmacology | Myocardial Reperfusion Injury - pathology | Cardioplegic Solutions - therapeutic use | Heart Rate - physiology | Recovery of Function - physiology | Models, Animal | Disaccharides - therapeutic use | Drug Therapy, Combination | Pyrazoles - pharmacology | Glutathione - therapeutic use | Mannitol - therapeutic use | Nitroglycerin - therapeutic use | Rats | Cardioplegic Solutions - pharmacology | Treatment Outcome | Myocardial Reperfusion Injury - physiopathology | Animals | Glutamates - pharmacology | Electrolytes - pharmacology | Hypothermia - physiopathology | Guanidines - therapeutic use | Myocardial Reperfusion Injury - prevention & control | Erythropoietin | Ischemia | Coronary heart disease
Journal Article
Science, ISSN 0036-8075, 9/2008, Volume 321, Issue 5895, pp. 1493 - 1495
Journal Article
Circulation, ISSN 0009-7322, 11/2004, Volume 110, Issue 19, pp. 3149 - 3155
STABLE ANGINA | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | ORAL SILDENAFIL | PULMONARY-HYPERTENSION | MYOCARDIAL-INFARCTION | PERIPHERAL VASCULAR DISEASE | CONTROLLED CLINICAL-TRIALS | SILDENAFIL-CITRATE | SEXUAL-ACTIVITY | CORONARY-ARTERY-DISEASE | BLOOD-PRESSURE | Myocardial Infarction - mortality | Isosorbide Dinitrate - analogs & derivatives | Phosphodiesterase Inhibitors - adverse effects | Cyclic Nucleotide Phosphodiesterases, Type 5 | Humans | Imidazoles - chemistry | Sulfones - adverse effects | Endothelium, Vascular - drug effects | Male | Piperazines - chemistry | Nitroglycerin - pharmacology | Sildenafil Citrate | Purines | Carbolines - chemistry | Drug Interactions | Imidazoles - therapeutic use | Triazines - pharmacology | Imidazoles - adverse effects | Imidazoles - pharmacology | Piperazines - therapeutic use | Arteriosclerosis - complications | Piperazines - adverse effects | Piperazines - pharmacology | Tadalafil | Cyclic GMP - metabolism | Vardenafil Dihydrochloride | Triazines - adverse effects | Vasodilation - drug effects | Myocardial Infarction - chemically induced | Phosphodiesterase Inhibitors - therapeutic use | Sulfones - therapeutic use | Triazines - therapeutic use | Vasodilator Agents - therapeutic use | Adrenergic alpha-Antagonists - pharmacology | Sulfones - pharmacology | Contraindications | Heart Rate - drug effects | Erectile Dysfunction - drug therapy | Sulfones - chemistry | Coronary Disease - complications | Triazines - chemistry | Blood Pressure - drug effects | Molecular Structure | Nitric Oxide Donors - pharmacology | Phosphodiesterase Inhibitors - chemistry | Carbolines - therapeutic use | Carbolines - adverse effects | Vasodilator Agents - pharmacology | Phosphodiesterase Inhibitors - pharmacology | Phosphoric Diester Hydrolases - drug effects | Hypotension - chemically induced | Isosorbide Dinitrate - pharmacology | Randomized Controlled Trials as Topic | 3',5'-Cyclic-GMP Phosphodiesterases | Vasodilator Agents - chemistry | Vasodilator Agents - adverse effects | Carbolines - pharmacology
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 12/2000, Volume 279, Issue 2, pp. 412 - 419
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 07/2015, Volume 172, Issue 13, pp. 3341 - 3352
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 09/2012, Volume 690, Issue 1-3, pp. 170 - 175
The reduced availability of nitric oxide (NO) is associated with cardiovascular diseases. Therefore, NO donors such as organic nitrates are useful for the... 
Vasorelaxation | Nitric oxide | Organic nitrate | POTASSIUM CHANNELS | INVOLVEMENT | NITROGLYCERIN INHALATION | VASCULAR SMOOTH-MUSCLE | INHIBITION | CYCLIC-GMP | ENDOTHELIUM | PHARMACOLOGY & PHARMACY | VASODILATION | HYPERTENSION | K+ CHANNELS | Free Radical Scavengers - pharmacology | Mesenteric Arteries - physiology | Nitric Oxide Donors - chemistry | Rats, Wistar | Nitrates - pharmacology | Male | Mesenteric Arteries - drug effects | Guanylate Cyclase - antagonists & inhibitors | Potassium Channels - metabolism | Quinoxalines - pharmacology | Propane - metabolism | Nitrates - chemistry | Phenylephrine - pharmacology | Propane - analogs & derivatives | Oxadiazoles - pharmacology | Vasodilator Agents - metabolism | Vasodilator Agents - chemical synthesis | Nitric Oxide Donors - pharmacology | Glycerol - chemistry | Myocytes, Smooth Muscle - drug effects | Myocytes, Smooth Muscle - cytology | Myocytes, Smooth Muscle - metabolism | Potassium Channel Blockers - pharmacology | Mesenteric Arteries - cytology | Nitric Oxide - biosynthesis | Propane - chemical synthesis | Intracellular Space - drug effects | Vasodilator Agents - pharmacology | Nitric Oxide Donors - metabolism | Rats | Soluble Guanylyl Cyclase | Vasoconstriction - drug effects | Nitrates - chemical synthesis | Propane - chemistry | Nitrates - metabolism | Animals | Intracellular Space - metabolism | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Vasodilator Agents - chemistry | Nitric Oxide Donors - chemical synthesis | Vasodilation - drug effects | In Vitro Techniques | Nitric Oxide - metabolism | Propane - pharmacology | Glycerin | Nitrogen oxide | Evaluation | Dilatation | Glycerol | Blood vessels | Nitrates | Glibenclamide | Polyols
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2016, Volume 60, Issue 9, pp. 5175 - 5181
The rapid, broad-spectrum, biofilm-eradicating activity of the combination of 0.01% nitroglycerin, 7% citrate, and 20% ethanol and its potential as a... 
MANAGEMENT | INTRAVENOUS NITROGLYCERIN | CHEST-PAIN | BACTEREMIA | HEMODIALYSIS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | TAUROLIDINE-CITRATE | CENTRAL VENOUS CATHETERS | HEPARIN | CANCER | BIOFILM FORMATION | Klebsiella pneumoniae - drug effects | Staphylococcus epidermidis - drug effects | Vancomycin-Resistant Enterococci - drug effects | Vancomycin-Resistant Enterococci - growth & development | Anti-Infective Agents - pharmacology | Escherichia coli - drug effects | Pseudomonas aeruginosa - growth & development | Biofilms - growth & development | Stenotrophomonas maltophilia - growth & development | Colony Count, Microbial | Candida albicans - growth & development | Nitroglycerin - pharmacology | Candida albicans - drug effects | Enterobacter cloacae - growth & development | Escherichia coli - growth & development | Acinetobacter baumannii - growth & development | Heparin - pharmacology | Biofilms - drug effects | Taurine - analogs & derivatives | Enterobacter cloacae - drug effects | Methicillin-Resistant Staphylococcus aureus - drug effects | Pseudomonas aeruginosa - drug effects | Candida glabrata - growth & development | Stenotrophomonas maltophilia - drug effects | Citrates - pharmacology | Ethanol - pharmacology | Methicillin-Resistant Staphylococcus aureus - growth & development | Catheters - microbiology | Staphylococcus epidermidis - growth & development | Anticoagulants - pharmacology | Klebsiella pneumoniae - growth & development | Taurine - pharmacology | Acinetobacter baumannii - drug effects | Thiadiazines - pharmacology | Candida glabrata - drug effects
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 03/2001, Volume 103, Issue 9, pp. 1282 - 1288
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 02/2012, Volume 91, Issue 2, pp. 289 - 297
Hypertension is associated with endothelial dysfunction and activated Rho‐associated kinases (ROCKs). The purpose of this study was to evaluate the effects of... 
SMOOTH-MUSCLE | ROCK ACTIVITY | CONVERTING ENZYME-INHIBITION | RENIN-ANGIOTENSIN SYSTEM | POSSIBLE INVOLVEMENT | PROTEIN-KINASE | HEART-FAILURE | DEPENDENT VASCULAR RELAXATION | NITRIC-OXIDE | CARDIOVASCULAR-DISEASE | PHARMACOLOGY & PHARMACY | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Endothelium, Vascular - drug effects | Hypertension - drug therapy | Male | Angiotensin II Type 1 Receptor Blockers - pharmacology | Leukocytes - enzymology | Nitroglycerin - pharmacology | rho-Associated Kinases - antagonists & inhibitors | Endothelium, Vascular - physiology | Spironolactone - pharmacology | Vascular Endothelial Growth Factor A - agonists | Nifedipine - therapeutic use | Mineralocorticoid Receptor Antagonists - pharmacology | Female | Hypertension - enzymology | Spironolactone - analogs & derivatives | Vasodilation - physiology | Spironolactone - therapeutic use | Nifedipine - pharmacology | Losartan - pharmacology | Calcium Channel Blockers - pharmacology | Hypertension - physiopathology | Mineralocorticoid Receptor Antagonists - therapeutic use | Cell Movement - drug effects | Eplerenone | Losartan - therapeutic use | Stem Cells - drug effects | Vasodilation - drug effects | Drugs | Hypertension | Dose-response relationship (Biochemistry) | Physiological aspects | Product/Service Evaluations | Drug therapy | Endothelium
Journal Article